eurekatherapeutics.comHealthcareFounded: 2006Funding to Date: $52.37MM
Eureka Therapeutics is a biotechnology company focused on breakthrough immunotherapies for the treatment of cancer.
For more details on financing and valuation for Eureka Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Eureka Therapeutics.
To read this article and more news on Eureka Therapeutics, register or login.